Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Morice

Showing results (111-120 of 284) with videos related to

Pageof 29
Sort By:
The Oncologist|June 11, 2011
Analysis of morbidity and clinical implications of laparoscopic para-aortic lymphadenectomy in a continuous series of 98 patients with advanced-stage cervical cancer and negative PET-CT imaging in the para-aortic areaCatherine Uzan, Amine Souadka, Sebastien Gouy, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 9, 2010
Outcome of patients with incomplete resection after surgery for stage IB2/II cervical carcinoma with chemoradiation therapyCatherine Uzan, Etienne Vincens, Corinne Balleyguier, et al.
Bulletin Du Cancer|January 11, 2012
[Postoperative vaginal brachytherapy in endometrial cancer]Renaud Mazeron, Wassim Khodari, Jennifer Gilmore, et al.
Annals of Surgical Oncology|August 26, 2010
Prognostic factors of a large retrospective series of mucinous borderline tumors of the ovary (excluding peritoneal pseudomyxoma)Martin Koskas, Catherine Uzan, Sebastien Gouy, et al.
Journal of the American College of Surgeons|September 17, 2002
Lymph node disorders and prognostic value of nodal involvement in patients treated for a borderline ovarian tumor: an analysis of a series of 42 lymphadenectomiesSophie Camatte, Philippe Morice, David Atallah, et al.
Gynecologic Oncology|October 20, 2004
Malignant female adnexal tumor of probable wolffian origin relapsing after pregnancyDavid Atallah, Roman Rouzier, Ioannis Voutsadakis, et al.
Bulletin Du Cancer|October 3, 2008
[Clinical practice guidelines 2008 for the surgical treatment, medical first-line and consolidation treatments of patients with epithelial ovarian cancer--update. According to the methodology of Standards, Options: Recommendations (SOR)]Catherine Lhommé, Philippe Morice, François Planchamp, et al.
Gynecologic Oncology|January 13, 2018
Dose-volume effects in pathologic lymph nodes in locally advanced cervical cancerWarren Bacorro, Isabelle Dumas, Alexandre Escande, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 9, 2025
Stage IA3 endometrial cancer in the FIGO 2023 classification: a case of clarity or complexity?Quentin Bachelin, Houssein El Hajj, Stéphanie Scherier, et al.
Human Reproduction (Oxford, England)|January 26, 2011
Fertility determinants after conservative surgery for mucinous borderline tumours of the ovary (excluding peritoneal pseudomyxoma)Martin Koskas, Catherine Uzan, Sebastien Gouy, et al.
Pageof 29

Showing results (111-120 of 284) with videos related to

Sort By:
Pageof 29
The Oncologist|June 11, 2011
Analysis of morbidity and clinical implications of laparoscopic para-aortic lymphadenectomy in a continuous series of 98 patients with advanced-stage cervical cancer and negative PET-CT imaging in the para-aortic areaCatherine Uzan, Amine Souadka, Sebastien Gouy, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 9, 2010
Outcome of patients with incomplete resection after surgery for stage IB2/II cervical carcinoma with chemoradiation therapyCatherine Uzan, Etienne Vincens, Corinne Balleyguier, et al.
Bulletin Du Cancer|January 11, 2012
[Postoperative vaginal brachytherapy in endometrial cancer]Renaud Mazeron, Wassim Khodari, Jennifer Gilmore, et al.
Annals of Surgical Oncology|August 26, 2010
Prognostic factors of a large retrospective series of mucinous borderline tumors of the ovary (excluding peritoneal pseudomyxoma)Martin Koskas, Catherine Uzan, Sebastien Gouy, et al.
Journal of the American College of Surgeons|September 17, 2002
Lymph node disorders and prognostic value of nodal involvement in patients treated for a borderline ovarian tumor: an analysis of a series of 42 lymphadenectomiesSophie Camatte, Philippe Morice, David Atallah, et al.
Gynecologic Oncology|October 20, 2004
Malignant female adnexal tumor of probable wolffian origin relapsing after pregnancyDavid Atallah, Roman Rouzier, Ioannis Voutsadakis, et al.
Bulletin Du Cancer|October 3, 2008
[Clinical practice guidelines 2008 for the surgical treatment, medical first-line and consolidation treatments of patients with epithelial ovarian cancer--update. According to the methodology of Standards, Options: Recommendations (SOR)]Catherine Lhommé, Philippe Morice, François Planchamp, et al.
Gynecologic Oncology|January 13, 2018
Dose-volume effects in pathologic lymph nodes in locally advanced cervical cancerWarren Bacorro, Isabelle Dumas, Alexandre Escande, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 9, 2025
Stage IA3 endometrial cancer in the FIGO 2023 classification: a case of clarity or complexity?Quentin Bachelin, Houssein El Hajj, Stéphanie Scherier, et al.
Human Reproduction (Oxford, England)|January 26, 2011
Fertility determinants after conservative surgery for mucinous borderline tumours of the ovary (excluding peritoneal pseudomyxoma)Martin Koskas, Catherine Uzan, Sebastien Gouy, et al.
Pageof 29